| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 41.05▼ | 41.05▼ | 41.05▼ | 40.90▼ | 40.08▲ |
| MA10 | 40.96▼ | 40.99▼ | 40.99▼ | 40.61▼ | 39.88▲ |
| MA20 | 40.96▼ | 41.00▼ | 40.93▼ | 40.20▲ | 40.53▼ |
| MA50 | 40.92▼ | 40.31▲ | 40.11▲ | 39.89▲ | 40.03▲ |
| MA100 | 40.33▲ | 40.44▲ | 40.53▼ | 40.46▲ | 38.48▲ |
| MA200 | 40.63▼ | 40.65▼ | 40.47▲ | 40.23▲ | 35.09▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.049▼ | -0.086▼ | -0.083▼ | 0.099▲ | -0.037▼ |
| RSI | 37.980▼ | 43.525▼ | 45.955▼ | 52.996▲ | 53.646▲ |
| STOCH | 43.673 | 43.673 | 42.621 | 71.286 | 50.963 |
| WILL %R | -100.000▼ | -100.000▼ | -100.000▼ | -60.406 | -36.765 |
| CCI | -152.239▼ | -165.753▼ | -170.471▼ | 53.479 | 59.062 |
|
Wednesday, November 04, 2026 06:00 AM
The data further validate the potential of EVX-04 as an off-the-shelf therapeutic vaccine for acute myeloid leukemiaData will be presented in a poster session at the American Society of Hematology ...
|
|
Tuesday, November 03, 2026 06:00 AM
Evaxion A/S (NASDAQ: EVAX) will present new biomarker data from its phase 2 trial with personalized cancer vaccine EVX-01 at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting ...
|
|
Tuesday, November 03, 2026 01:01 AM
New data from the phase 2 trial with EVX-01 to be presented in both an oral and poster session COPENHAGEN, Denmark, November 3, 2026 - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 05/11/26 | 41.30 | 41.30 | 40.41 | 40.53 | 14,900 |
| 04/11/26 | 41.49 | 41.72 | 41.09 | 41.72 | 11,602 |
| 03/11/26 | 41.00 | 41.01 | 40.80 | 40.83 | 9,500 |
| 02/11/26 | 40.50 | 41.21 | 40.50 | 41.10 | 7,100 |
| 30/10/26 | 40.33 | 40.71 | 40.12 | 40.32 | 10,000 |
| 29/10/26 | 39.83 | 40.42 | 39.83 | 40.42 | 10,200 |
| 28/10/26 | 40.05 | 40.21 | 39.77 | 39.82 | 9,100 |
| 27/10/26 | 40.53 | 40.54 | 40.16 | 40.16 | 10,300 |
| 26/10/26 | 40.64 | 40.76 | 40.60 | 40.67 | 4,800 |
| 23/10/26 | 40.26 | 40.68 | 40.26 | 40.54 | 5,300 |
|
|
||||
|
|
||||
|
|